One dose of the Jynneos vaccine was 58% effective against mpox infection overall and 84% in people without HIV, but only 35% ...
Emergent BioSolutions struggles with declining revenues, rising competition, and weak growth prospects. Read why I rate EBS ...
Universitätsmedizin Berlin has found that a single dose of the Imvanex vaccine provides protection against mpox with 84% ...
Viruses like SARS-CoV-2 use sugar molecules to hide from the immune system, but scientists at Scripps Research have designed ...
Sugar coatings aren't only for candies; they also help viruses, like the ones that cause COVID-19, hide from their hosts' ...
A study has found that a single dose of the Imvanex vaccine provides protection against Mpox with 84% effectiveness. For people with HIV, however, a single dose of the vaccine fails to offer ...
Researchers at the Scripps Research have revealed that “sugar coatings aren’t only for candies; they also help viruses, like ...
EQS-News: GeoVax, Inc. / Key word (s): Financial GeoVax Reports 2024 Year-End Financial Results and Provides Business Update 27.03.2025 / 21:06 CET/CEST The issuer is solely responsible for the ...
The history, impact, and resurgence of measles due to vaccine hesitancy, highlighting the need for public health education.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback